Abstract
A 46-year-old woman presented with malignant ophthalmopathy 1 week after a therapeutic dose of radioiodine for treatment of hyperthyroidism. The patient was a smoker and had clinical evidence of mild thyroid-associated ophthalmopathy (TAO) prior to treatment with radioiodine. Anti-thyrotropin (TSH) receptor antibodies and antiflavoprotein antibodies were not detected at the time of presentation with malignant ophthalmopathy. The patient responded rapidly to anti-inflammatory treatment with intravenous methylprednisolone and orbital radiation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 189-192 |
| Number of pages | 4 |
| Journal | Thyroid |
| Volume | 9 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 1999 |
Fingerprint
Dive into the research topics of 'Malignant ophthalmopathy presenting one week after radioiodine treatment of hyperthyroidism'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS